Rituximab for Serious Aplastic Anemia With Platelet Transfusion Refractoriness

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Rituximab for Serious Aplastic Anemia With Platelet Transfusion Refractoriness	Bone Marrow Failure Disorders, Hemic and Lymphatic Diseases, anemia, aplastic anemia, bone marrow disorder, hematologic disorder	Recruiting	Phase 2	2024-02-12		NCT06254560

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Institute of Hematology & Blood Diseases Hospital, China	285

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences	Tianjin	China	1

Clinical trials